SOURCE: IDenta Corp.

January 28, 2008 13:08 ET

International Drug & Explosives Detection Firm IDenta Corp. Continues Expansion -- Adds More Countries to World-Wide Marketing Network

JERUSALEM--(Marketwire - January 28, 2008) - IDenta Corp. (PINKSHEETS: IDTA) announced today that it has added new firms to its network of international representatives. Companies in Turkey, Malaysia-Singapore, Holland-Belgium, Denmark-Sweden-Norway-Finland (Scandinavian countries) have recently signed agreements to represent IDenta's growing line of proprietary, on-site drug detection, explosive identification, and BTK (Bullet Test Kit) products. IDenta's newly signed representatives are:

1. ITM Foreign Trade Ltd. from Ankara, Turkey, www.itmsecurity.com.tr, is representing IDenta Corp. in Turkey.

2. TYTAN Engineering (S) Pte. Ltd. from Singapore, www.freefromdanger.com, is representing IDenta in Singapore-Malaysia.

3. Loci Forensic Products from Holland, http://www.lociforensicproducts.nl/, is the authorized representative of IDenta Corp. in Holland - Belgium.

4. Medicoline Tekline, Dubai UAE, from Denmark will represent IDenta's products in the Scandinavian countries.

ABOUT IDENTA

Since 2003, IDenta Corporation has become recognized as a world-wide leader in the development of proprietary on-site drug and explosive detection kits. IDenta develops, manufactures and distributes products for the both professional and civil markets which consistently pass the highest qualifications and testing procedures of law enforcement and security agencies around the world. Information concerning IDenta's entire product line may be found at www.IDenta.biz

DISCLAIMER

Certain of the statements contained herein may be, within the meaning of the federal securities laws, "forward-looking statements" that are subject to risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. Such forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the company to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. These forward-looking statements are based on management's expectations as of the date hereof, and the company does not undertake any responsibility to update any of these statements in the future.

Contact Information

  • For Investor Relations, lobbying interests or information concerning
    IDenta's products internationally, contact:
    Yaacov Shoham
    IDenta Corp.
    CEO
    Tel: +972-52-6554487
    fpi@drugsdetector.com

    For Investor Relations in the US, contact:
    Randy Jacobs
    Corporate Spokesman
    IDentaNews@sitcomllc.com
    1-800-316-9437

    For information about the Accutest® - IDenta products in the US, please
    contact:
    Mr. Eyal Golan
    COO
    JANT PHARMACAL CORPORATION
    16255 Ventura Blvd. #505
    Encino, CA 91436
    Toll Free: 800-676-5565
    www.accutest.net